eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2012
vol. 16
 
Share:
Share:
abstract:
Review paper

Comparative proteomics in acute myeloid leukemia

Magdalena Luczak
,
Maciej Kaźmierczak
,
Luiza Hadschuh
,
Krzysztof Lewandowski
,
Mieczysław Komarnicki
,
Marek Figlerowicz

Wspolczesna Onkol 2012; 16 (2): 95–103
Online publish date: 2012/05/29
View full text Get citation
 
PlumX metrics:
The term proteomics was used for the first time in 1995 to describe large-scale protein analyses. At the same time proteomics was distinguished as a new domain of the life sciences. The major object of proteomic studies is the proteome, i.e. the set of all proteins accumulating in a given cell, tissue or organ. During the last years several new methods and techniques have been developed to increase the fidelity and efficacy of proteomic analyses. The most widely used are two-dimensional electrophoresis (2DE) and mass spectrometry (MS).

In the past decade proteomic analyses have also been successfully applied in biomedical research. They allow one to determine how various diseases affect the pattern of protein accumulation. In this paper, we attempt to summarize the results of the proteomic analyses of acute myeloid leukemia (AML) cells. They have increased our knowledge on the mechanisms underlying AML development and contributed to progress in AML diagnostics and treatment.
keywords:

acute myeloid leukemia, proteomics, 2DE, mass spectrometry

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.